| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/06/2001 | US20010019834 Genetic engineering |
| 09/06/2001 | US20010019828 Generating an immune response to lymphoma |
| 09/06/2001 | US20010019716 Ability to enter mammalian cells and to survive within macrophages; vaccines to prevent infection by Mycobacterium tuberculosis, diagnostic assays |
| 09/06/2001 | US20010019715 Administering a cytotoxic T-lymphocyte and one agent capable of neutralizing or down regulating the activity of tumor secreted immunosuppressive factors |
| 09/06/2001 | US20010019714 Hiv-specific cytotoxic t-cell responses |
| 09/06/2001 | DE10006889A1 Verwendung von Inhibitoren von Caspase-3 oder der Caspase-aktivierten Desoxyribonuclease (CAD) zur Behandlung von Herzerkrankungen Use of inhibitors of caspase-3 or caspase-activated deoxyribonuclease (CAD) for the treatment of heart disease |
| 09/05/2001 | EP1130088A1 Hybrid cell vaccines |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1129728A1 Methods and compositions for the selective modification of nucleic acids |
| 09/05/2001 | EP1129724A2 Vaccines for treating colon cancer |
| 09/05/2001 | EP1129723A1 Combined vaccine against both hav and measle virus and method of producing it |
| 09/05/2001 | EP1129722A1 gM-negative EHV-mutants |
| 09/05/2001 | EP1129717A1 Use of homologues of staphylococcal enterotoxins for cancer treatment |
| 09/05/2001 | EP1129202A2 Chlamydia antigenes and corresponding dna fragments and uses thereof |
| 09/05/2001 | EP1129199A2 Cell signaling polypeptides and nucleic acids |
| 09/05/2001 | EP1129197A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN |
| 09/05/2001 | EP1129196A2 Virulence genes and proteins, and their use |
| 09/05/2001 | EP1129195A2 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains |
| 09/05/2001 | EP1129191A1 Methods of diagnosing or treating neurological diseases |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1129177A1 Avipox vector coding an hiv antigen and a cytokine |
| 09/05/2001 | EP1129110A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 09/05/2001 | EP1128848A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 09/05/2001 | EP1128843A2 Vaccine against papillomatous digital dermatitis (pdd) |
| 09/05/2001 | EP0832107B1 An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine |
| 09/05/2001 | EP0826003B1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome |
| 09/05/2001 | EP0513090B1 Hepatitis a vaccines |
| 09/05/2001 | CN1311820A BASB027 protein and genes from i(Moraxella Catarrhalis), antigens, antibodies, and uses |
| 09/05/2001 | CN1311797A Process for producing immunolobulins for intravenous administration and other immunolobulin products |
| 09/05/2001 | CN1311795A Method for purification of i(Borrelia) lipoprotein OSPA |
| 09/05/2001 | CN1311691A Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 09/05/2001 | CN1311690A Porcine circovirus and parvovirus vaccine |
| 09/05/2001 | CN1311689A Viral chimeras comprised of CAEV and HIV-1 genetic elements |
| 09/05/2001 | CN1311688A Synthetic somatostatin immunogen for growth promotion in farm animals |
| 09/05/2001 | CN1311686A Pulmonary delivery of active agents |
| 09/05/2001 | CN1311257A Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom |
| 09/05/2001 | CN1311037A Piglet red dysentery welch's fusiform bacillus alpha-beta toxin bivalent gene engineering vaccine and preparing method |
| 09/05/2001 | CN1311036A Mixed vaccine for anti-vibrisis of seawater cultivation amimals with its preparing method |
| 09/05/2001 | CN1070611C Hybridoma cell lines and thier monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 09/05/2001 | CN1070381C Oral hydrophobia vaccine for dog and prodn. process therefor |
| 09/05/2001 | CN1070371C Medicine for treating HIV-seropositive individuals medicine |
| 09/04/2001 | US6284884 Depolymerization and reacting with base to form de-n-acetylated polysaccharide; reacting with nitrosation agent |
| 09/04/2001 | US6284881 A nucleic acid molecule; diagnosis and therpy for allergies, parasitic infections, b cell neoplasia and atopic diseases |
| 09/04/2001 | US6284879 A nucleic acid encoding a transporter protein; treatment of autoimmune disorders and improving immune responses |
| 09/04/2001 | US6284878 def1 |
| 09/04/2001 | US6284733 Polypeptides |
| 09/04/2001 | US6284532 Purified human papillomavirus |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284507 Mitofusin genes and their uses |
| 09/04/2001 | US6284489 Enzymatic polypeptide for use in screening bactericides; wound healing agents; for prevention of bacterial infections |
| 09/04/2001 | US6284477 Diagnostic method of use of OMP26 antigen from Haemophilus influenzae |
| 09/04/2001 | US6284476 Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals |
| 09/04/2001 | US6284464 Inhibition of binding of Hox and homeodomain-containing proteins and uses thereof |
| 09/04/2001 | US6284454 Variant of LAV viruses |
| 09/04/2001 | US6284256 Bordetella bronchiseptica vaccine |
| 09/04/2001 | US6284255 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/04/2001 | US6284254 Vaccines |
| 09/04/2001 | US6284253 Aids in cats |
| 09/04/2001 | US6284251 Bovine herpes virus |
| 09/04/2001 | US6284250 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media |
| 09/04/2001 | US6284249 Fusion polypeptide having the C protein and E1 protein of hepatitis C virus |
| 09/04/2001 | US6284245 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 09/04/2001 | US6284240 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 09/04/2001 | US6284239 Murine model for human carcinoma |
| 09/04/2001 | US6284238 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
| 09/04/2001 | US6284237 Methods of treatment using IL-6 |
| 09/04/2001 | CA2116753C Monoclonal antibodies recognizing the epidermal growth factor-receptor, cells and methods for producing them and compositions containing them |
| 08/30/2001 | WO2001063295A2 Dpi-6, a therapeutic biomarker in neurological disorders |
| 08/30/2001 | WO2001063290A1 Bcmp-7 as marker for diagnosis of breast cancer |
| 08/30/2001 | WO2001063289A1 Diagnosis of breast cancer using bcmp-11 as marker |
| 08/30/2001 | WO2001063288A1 Diagnosis of breast cancer using bcmp-81 as marker |
| 08/30/2001 | WO2001063278A2 Antigenic fragments associated with stress-induced proteins and their use as vaccines |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062932A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 08/30/2001 | WO2001062924A2 Human g protein-coupled receptors |
| 08/30/2001 | WO2001062920A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062913A1 Vertebrate globin |
| 08/30/2001 | WO2001062902A1 Hybrid cell vaccines |
| 08/30/2001 | WO2001062802A1 Treatment of hookworm infection |
| 08/30/2001 | WO2001062801A2 Humanized antibodies that sequester amyloid beta peptide |
| 08/30/2001 | WO2001062800A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
| 08/30/2001 | WO2001062786A2 Tlp peptides and dna sequences coding the same |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062776A1 Hla binding peptides and their uses |
| 08/30/2001 | WO2001062300A2 Caspase activated prodrugs therapy |
| 08/30/2001 | WO2001062298A2 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 08/30/2001 | WO2001062288A1 Membrane estrogen receptor-directed therapy in breast cancer |
| 08/30/2001 | WO2001062287A1 Methods of prevention and treatment of asthma, and allergic conditions |
| 08/30/2001 | WO2001062286A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | WO2001062285A1 Use of il-18 inhibitors |
| 08/30/2001 | WO2001062284A2 Novel method for down-regulation of amyloid |
| 08/30/2001 | WO2001062283A2 Mucosal adjuvant formulation |
| 08/30/2001 | WO2001062282A2 Adjuvants for vaccines |
| 08/30/2001 | WO2001062275A1 Adjuvant treatment by in vivo activation of dendritic cells |
| 08/30/2001 | WO2001062271A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/30/2001 | WO2001062266A2 Use of dpp-iv inhibitors for the treatment of diabetes |
| 08/30/2001 | WO2001062240A2 Use of zwitterion-type detergent for preparing a pharmaceutical composition for nasal delivery |
| 08/30/2001 | WO2001062228A1 Method for transdermal or intradermal delivery of molecules |